WO2021231913A1 - Systems and methods for simultaneous wound detection and therapy - Google Patents

Systems and methods for simultaneous wound detection and therapy Download PDF

Info

Publication number
WO2021231913A1
WO2021231913A1 PCT/US2021/032527 US2021032527W WO2021231913A1 WO 2021231913 A1 WO2021231913 A1 WO 2021231913A1 US 2021032527 W US2021032527 W US 2021032527W WO 2021231913 A1 WO2021231913 A1 WO 2021231913A1
Authority
WO
WIPO (PCT)
Prior art keywords
photons
condition
tissue
light
interacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2021/032527
Other languages
French (fr)
Inventor
Shona Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ChemImage Corp
Original Assignee
ChemImage Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ChemImage Corp filed Critical ChemImage Corp
Priority to CN202180048387.6A priority Critical patent/CN115867199A/en
Priority to JP2022568673A priority patent/JP2023526026A/en
Priority to EP21804665.4A priority patent/EP4149359A4/en
Publication of WO2021231913A1 publication Critical patent/WO2021231913A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0082Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence adapted for particular medical purposes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0033Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room
    • A61B5/0036Features or image-related aspects of imaging apparatus, e.g. for MRI, optical tomography or impedance tomography apparatus; Arrangements of imaging apparatus in a room including treatment, e.g., using an implantable medical device, ablating, ventilating
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A61B5/0077Devices for viewing the surface of the body, e.g. camera, magnifying lens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/444Evaluating skin marks, e.g. mole, nevi, tumour, scar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/44Detecting, measuring or recording for evaluating the integumentary system, e.g. skin, hair or nails
    • A61B5/441Skin evaluation, e.g. for skin disorder diagnosis
    • A61B5/445Evaluating skin irritation or skin trauma, e.g. rash, eczema, wound, bed sore
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/0616Skin treatment other than tanning
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/0613Apparatus adapted for a specific treatment
    • A61N5/062Photodynamic therapy, i.e. excitation of an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/48Other medical applications
    • A61B5/4848Monitoring or testing the effects of treatment, e.g. of medication
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7225Details of analogue processing, e.g. isolation amplifier, gain or sensitivity adjustment, filtering, baseline or drift compensation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0626Monitoring, verifying, controlling systems and methods
    • A61N2005/0627Dose monitoring systems and methods
    • A61N2005/0628Dose monitoring systems and methods including a radiation sensor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0651Diodes
    • A61N2005/0653Organic light emitting diodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0654Lamps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/065Light sources therefor
    • A61N2005/0656Chemical light sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0659Radiation therapy using light characterised by the wavelength of light used infrared
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0661Radiation therapy using light characterised by the wavelength of light used ultraviolet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N2005/0658Radiation therapy using light characterised by the wavelength of light used
    • A61N2005/0662Visible light
    • A61N2005/0663Coloured light
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/06Radiation therapy using light
    • A61N5/067Radiation therapy using light using laser light

Definitions

  • the present disclosure relates generally to systems and methods for simultaneous medical imaging and therapy. More particularly, light of specified wavelength and intensity is applied both to generate useful images and to treat certain conditions.
  • Light is used in medical imaging to non-invasively identify various structures that are of interest in medical procedures and diagnostics.
  • light of various wavelengths can be used to create hyperspectral images that identify skin lesions, tumors, and even levels of tissue oxygenation.
  • the advantages of using light are many, including the avoidance of invasive tests like biopsies or even exploratory surgery and the simplicity by which light is generated and directed to organs and other anatomical structures.
  • Light is also used in medical therapies to treat conditions of skin and other organs, as well as improve psychological wellbeing.
  • light can also be used to trigger the release or action of pharmaceutical compounds.
  • Such triggered or released pharmaceutical compounds can have myriad uses, including treating the body directly or interacting with other useful compounds that treat the body.
  • a method of imaging and treating a condition of a tissue comprising: generating photons with a light source; directing the generated photons to a tissue, said tissue comprising the condition; interacting the generated photons with the tissue, the condition, or both the tissue and the condition in order to treat the condition, simultaneously to the interacting, collecting interacted photons that have interacted with the tissue, the condition, or both the tissue and the condition; directing the collected and interacted photons to a camera chip, generating, by way of the camera chip, an image from the collected, interacted photons.
  • the condition is one or more of a wound, a cancer, a non- cancerous tumor, a skin lesion, or a pre-cancerous skin lesion.
  • treating the condition is performed photodynamically.
  • the photodynamic treatment includes application of a photosensitizing agent to one or more of the tissue or the condition.
  • treating the condition is performed by the direct therapeutic effect of interacting the generated photons with the tissue or the condition.
  • treating the condition is performed photodynamically by applying a photosensitizing agent to one or more of the tissue or the condition and by the direct therapeutic effect of interacting the generated photons the tissue or the condition.
  • the generated photons have wavelengths of one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), or near infrared-extended shortwave infrared (NIR-eSWIR).
  • UV ultraviolet
  • VIS near infrared
  • VIS-NIR visible-near infrared
  • SWIR shortwave infrared
  • eSWIR extended shortwave infrared
  • NIR-eSWIR near infrared-extended shortwave infrared
  • the generated photons are UV.
  • the light source comprises one or more of an incandescent lamp, a halogen lamp, a light emitting diode (LED), a chemical laser, a solid state laser, an organic light emitting diode (OLED), an electroluminescent device, a fluorescent light, a gas discharge lamp, a metal halide lamp, a xenon arc lamp, and an induction lamp.
  • the light source is tunable.
  • the method further comprising filtering the interacted photons.
  • the method further comprises filtering interacted photons, and the filtering interacted photons is performed by one or more of a fixed filter, a multi conjugate filter, and a conformal filter.
  • the method further comprises determining the existence of the condition before generating photons, directing the generated photons, interacting the generated photons, directing the collected and interacted photons, and generating an image.
  • determining the existence of the condition includes separate antecedent steps to the steps of generating photons, directing the generated photons, interacting the generated photons, and directing the collected and interacted photons, and the antecedent steps comprise: antecedently generating photons, antecedently collecting photons, antecedently interacting photons, and antecedently directing the photons, to thereby diagnose the condition.
  • At least one light source that generates photons that are directed to a human or animal.
  • the light source is not limited and can be any source that is useful in providing the illumination.
  • the at least one light source may be used in concert with or attached to endoscope. Other ancillary requirements, such as power consumption, emitted spectra, packaging, thermal output, and so forth may be determined based on the particular application that the at least one light source is used.
  • the light source is a light element, which is an individual device that emits light.
  • the light elements are not limited and may include an incandescent lamp, halogen lamp, light emitting diode (LED), chemical laser, solid state laser, organic light emitting diode (OLED), electroluminescent device, fluorescent light, gas discharge lamp, metal halide lamp, xenon arc lamp, induction lamp, or any combination of these light sources.
  • the light source is a light array, which is a grouping or assembly of more than one light element that are placed in proximity to each other.
  • a light source has a particular wavelength that is intrinsic to the light element or to the light array.
  • the wavelength of the light sources is modified by filtering or tuning the photons that are emitted by the light source.
  • light sources having different wavelengths are combined.
  • the selected wavelength of a light source is not limited and can be one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), and near infrared-extended shortwave infrared (NIR- eSWIR) ranges.
  • UV ranges of about 180 nm to about 380 nm
  • VIS 380 nm to about 720 nm
  • SWIR 850 nm to about 1800 nm
  • eSWIR about 1200 nm to about 2450 nm
  • NIR-eSWIR 720 nm to about 2500 nm
  • Violet light has a wavelength of about 380 to about 450 nm
  • blue light has a wavelength of about 450 to about 485 nm
  • cyan light has a wavelength of about 485 to about 500 nm
  • green light has a wavelength of about 500 nm to 565 nm
  • yellow light has a wavelength of about 565 nm to about 590 nm
  • orange light has a wavelength of about 590 nm to about 625 nm
  • red light has a wavelength of about 625 nm to about 720 nm.
  • the light source is a modulated light source.
  • the choice of modulated light source and the techniques of modulating the light source are not limited.
  • the modulated light source is one or more of a filtered incandescent lamp, filtered halogen lamp, tunable LED array, tunable solid state laser array, tunable OLED array, tunable electroluminescent device, filtered fluorescent light, filtered gas discharge lamp, filtered metal halide lamp, filtered xenon arc lamp, filtered induction lamp, or any combination of these light sources.
  • tuning is accomplished by increasing or decreasing the intensity or duration at which the individual light elements are powered.
  • tuning is accomplished by a fixed or tunable filter that filters light emitted by the individual light elements.
  • the light source is not tunable.
  • a light source that is not tunable cannot change its emitted light spectra, but it can be turned on and off by the appropriate controls.
  • the light source comprises a quartz tungsten halogen light source.
  • the illumination source may comprise a metal halide light source, a light emitting diode (LED), a LED array having a uniform selection of emitters which emit over a constant wavelength range or a plurality of emitters which emit over a diversity of wavelength ranges, a pulsed LED, a pulsed LED array, a laser, a pulsed laser, a broadband illumination source, gas discharge light source, a fluorescent light source, an arc light source, a xenon arc lamp source, an LED light source in combination with phosphors and/or quantum dots, and the like and combinations thereof.
  • LED light emitting diode
  • the illumination sources are selected depending on the wavelengths of interest, and in particular whether a wavelength can not only be therapeutic, but also diagnostic in nature.
  • the lasers and/or LED light sources may be selected depending on the wavelengths of interest.
  • the lasers may be gas discharge or solid state or semiconductor lasers and include helium-neon, argon, krypton, xenon ion, nitrogen, carbon monoxide, eximer, dye lasers such as stilbene, coumarin, and rhodamine, solid state or semiconductor lasers such as ruby, Nd:YAG, NdCrYAG, Nd:YLF, Nd:YV04, Nd:YCa404, Nd:YCa 4 0(B0 3 ) 3 , Nd:glass, Tksapphire, Tr YAG, Tb:YAG, Yb doped glass, Ho:YAG, Cr:ZnSe, Ce:LiSAF, Ce:LiCAF, GaN, InGaN
  • the illumination source may have a fixed spectral emission or may be tunable by combining sources, filtering, and/or modulating the sources and/or filters. Depending on the size, thermal output, power requirements, and so forth, the illumination source may be used directly within an a system, or remotely via optical fibers that are transparent to the desired wavelengths.
  • the light sources of the present disclosure are configured so that, when activated, the light emitted by the light sources achieves therapeutic effects in a human or animal patient.
  • the therapeutic effects are not limited.
  • the light achieves direct therapeutic effect by interacting with body tissue.
  • the light achieves direct therapeutic effect by interacting with the body tissue and the condition.
  • the light is used in photodynamic therapy where the application of light releases a therapeutic composition, and that therapeutic composition achieves the therapeutic effect.
  • the light simultaneously achieves direct therapeutic effect and photodynamic effect.
  • the direct therapeutic effect can be achieved by the light interacting with the body tissue, the condition, or both the body tissue and the condition.
  • the light has a direct therapeutic effect and is in the UV spectrum.
  • the light can treat one or more of atopic dermatitis, psoriasis, vitiligo, acne vulgaris, cancer, and wounds.
  • the light has a direct therapeutic effect, and the wavelength of the light is one or more of UV, red, blue, NIR, VIS- NIR, SWIR, eSWIR, NIR-eSWIR, and full spectrum.
  • the light does not achieve a direct effect and is instead used to perform photodynamic therapy.
  • the light is directed to a photosensitizer drug that releases therapeutically beneficial or therapeutically active compounds.
  • the list of conditions that respond to a treatment of the type disclosed herein is not limited and includes one or more of wounds, cancer, non-cancerous tumors, skin lesions, and precancerous skin lesions.
  • the light is also used for visualization.
  • the light that is used for simultaneous visualization and therapy is directed to the organs, skin, or other body tissues that are the subject of treatment.
  • Examples of the light that is used for simultaneous visualization and therapy includes one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), and near infrared-extended shortwave infrared (NIR-eSWIR) ranges.
  • the light is ultraviolet (UV).
  • the spectral range of the light is alternated over time. Alternating or changing the spectral range of the light can be accomplished by switching light elements on or off individually, switching sections of the light array on or off individually, or switching an entire light array on or off.
  • Imaging is performed by filtering and detecting photons that are reflected from the body of the human or animal patient.
  • the techniques and devices for filtering are not limited and include any of fixed filters, multi-conjugate filters, and conformal filters. In fixed filters, the functionality of the filter cannot be changed, though the filtering can be changed by mechanically moving the filter into or out of the light path.
  • the filter is a tunable filter that comprises a multi-conjugate filter.
  • the multi-conjugate filter is an imaging filter with serial stages along an optical path in a Sole filter configuration. In such filters, angularly distributed retarder elements of equal birefringence are stacked in each stage with a polarizer between stages.
  • a conformal filter can filter a broadband spectra into one or more passbands.
  • Example conformal filters include a liquid crystal tunable filter, an acousto-optical tunable filter, a Lyot liquid crystal tunable filter, an Evans Split-Element liquid crystal tunable filter, a Sole liquid crystal tunable filter, a Ferroelectric liquid crystal tunable filter, a Fabry Perot liquid crystal tunable filter, and combinations thereof.
  • the image is collected by a camera chip.
  • the camera chip is not limited, but in some embodiments is selected depending on the expected spectra that is reflected from the skin, tissues, or organs of the human or animal patient.
  • the camera chip is one or more of a charge coupled device (CCD), a complementary metal oxide semiconductor (CMOS), an indium gallium arsenide (InGaAs) camera chip, a platinum silicide (PtSi) camera chip, an indium antimonide (InSb) camera chip, a mercury cadmium telluride (HgCdTe) camera chip, or a colloidal quantum dot (CQD) camera chip.
  • CCD charge coupled device
  • CMOS complementary metal oxide semiconductor
  • InGaAs indium gallium arsenide
  • PtSi platinum silicide
  • InSb indium antimonide
  • HgCdTe mercury cadmium telluride
  • CQD colloidal quantum dot
  • each or the combination of the above-listed camera chips is a focal plane array (FPA).
  • each of the above camera chips includes quantum dots to tune their bandgaps thereby altering or expanding sensitivity to different wavelengths.
  • the visualization techniques are not limited, and include one or more of VIS, NIR, SWIR, autofluorescence, or Raman spectroscopy.
  • the systems and methods include the ablation of body tissue by solid state lasers or chemical lasers.
  • the tissue can be one or more of skin or organs.
  • the visualization is performed at the same time or with at least some overlapping time with therapy.
  • Such embodiments might be selected, for example, in situations where it is known or likely that a patient has a condition that needs to be treated. For example, a patient with a previously diagnosed condition can be safely visualized and treated at the same time without any prior diagnostic imaging.
  • the systems and methods described herein for performing visualization are confirmatory and can be used to analyze the condition as treatment continues.
  • an additional antecedent series of visualization steps are performed before therapy. Such embodiments might be selected, for example, in situations where it is not known or not likely that a patient has a condition that needs to be treated. For example, for a patient suspected but not diagnosed with a condition, antecedent visualization will be performed before any treatment is performed. In such instance, the same systems and methods described herein are used to both diagnose and treat the condition.
  • the antecedent visualization can, in certain embodiments, include the same steps described herein for visualization, but they are performed before any simultaneous treatment and visualization is performed.
  • the disclosure further contemplates that the same system or method performs both the visualization and the therapy, thereby saving time and resources. Furthermore, in those embodiments where the patient is known or likely to have a condition, the disclosure saves even further time and resources by enabling the same system or method to both treat and monitor the patient.
  • a tunable laser array light source was provided and includes two tunable laser light elements. When switched on, each laser light element produced a different wavelength. The light that was output from the light array was directed to a test tissue that contained a precancerous lesion. A photosensitizing agent was applied to the tissue. A dual polarization conformal filter was also placed to receive photons that interacted with the tissue. A CCD camera chip located on the opposite side of the conformal filter from the tissue was configured to output hyperspectral images of the tissue based on the photons that interacted with the tissue and were further modified by the dual polarization conformal filter.
  • the above configuration captured hyperspectral images and generated a ratiometric score image.
  • the ratiometric score image had increased contrast in comparison to images that were not generated with the combination of the tuned light source and the dual polarization conformal filter.
  • the increased contrast permitted easier identification of the precancerous lesion.
  • the light that was produced by the tunable laser array light source also caused the photosensitizing agent to release therapeutically beneficial compounds.
  • the precancerous legion was not only identified by imaging light that interacted with it, but therapeutic treatment was simultaneously performed by way of the release of the photosensitizing agent.
  • compositions, methods, and devices are described in terms of “comprising” various components or steps (interpreted as meaning “including, but not limited to”), the compositions, methods, and devices can also “consist essentially of’ or “consist of’ the various components and steps, and such terminology should be interpreted as defining essentially closed-member groups. It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present.
  • a system having at least one of A, B, or C would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, et cetera). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
  • a range includes each individual member.
  • a group having 1-3 cells refers to groups having 1, 2, or 3 cells.
  • a group having 1-5 cells refers to groups having 1, 2, 3, 4, or 5 cells, and so forth.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Dermatology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Endoscopes (AREA)

Abstract

Medical conditions in tissues are simultaneously imaged and treated using light within selected wavelength ranges. By treating conditions, such as wounds, lesions, and tumors, at the same time that they are imaged, the overall diagnostic and treatment time is substantially reduced.

Description

SYSTEMS AND METHODS FOR SIMULTANEOUS WOUND DETECTION AND
THERAPY
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of U.S. Provisional Patent Application No. 63/024,728 filed May 14, 2020, the entirety of which is incorporated by reference herein.
FIELD
[0002] The present disclosure relates generally to systems and methods for simultaneous medical imaging and therapy. More particularly, light of specified wavelength and intensity is applied both to generate useful images and to treat certain conditions.
BACKGROUND
[0003] Light is used in medical imaging to non-invasively identify various structures that are of interest in medical procedures and diagnostics. For example, light of various wavelengths can be used to create hyperspectral images that identify skin lesions, tumors, and even levels of tissue oxygenation. The advantages of using light are many, including the avoidance of invasive tests like biopsies or even exploratory surgery and the simplicity by which light is generated and directed to organs and other anatomical structures.
[0004] Light is also used in medical therapies to treat conditions of skin and other organs, as well as improve psychological wellbeing. In addition to light exposure being an effective therapeutic treatment in and of itself, light can also be used to trigger the release or action of pharmaceutical compounds. Such triggered or released pharmaceutical compounds can have myriad uses, including treating the body directly or interacting with other useful compounds that treat the body.
[0005] Even so, there is a continual need for medical treatments and diagnostic tests that are efficient and minimally invasive. In particular, it would be desirable to combine the diagnostic and imaging capabilities of various light spectra with the therapeutic capabilities of the same or similar spectra. SUMMARY
[0006] This summary is provided to comply with 37 C.F.R. § 1.73, requiring a summary of the invention briefly indicating the nature and substance of the invention. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims.
[0007] In one embodiment, there is a method of imaging and treating a condition of a tissue, the method comprising: generating photons with a light source; directing the generated photons to a tissue, said tissue comprising the condition; interacting the generated photons with the tissue, the condition, or both the tissue and the condition in order to treat the condition, simultaneously to the interacting, collecting interacted photons that have interacted with the tissue, the condition, or both the tissue and the condition; directing the collected and interacted photons to a camera chip, generating, by way of the camera chip, an image from the collected, interacted photons.
[0008] In another embodiment, the condition is one or more of a wound, a cancer, a non- cancerous tumor, a skin lesion, or a pre-cancerous skin lesion.
[0009] In another embodiment, treating the condition is performed photodynamically.
[0010] In another embodiment, the photodynamic treatment includes application of a photosensitizing agent to one or more of the tissue or the condition.
[0011] In another embodiment, treating the condition is performed by the direct therapeutic effect of interacting the generated photons with the tissue or the condition.
[0012] In another embodiment, treating the condition is performed photodynamically by applying a photosensitizing agent to one or more of the tissue or the condition and by the direct therapeutic effect of interacting the generated photons the tissue or the condition.
[0013] In another embodiment, the generated photons have wavelengths of one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), or near infrared-extended shortwave infrared (NIR-eSWIR). [0014] In another embodiment, the generated photons are VIS and have one or more wavelength ranges corresponding to violet, blue, cyan, green, yellow, orange, or red.
[0015] In another embodiment, the generated photons are UV.
[0016] In another embodiment, the light source comprises one or more of an incandescent lamp, a halogen lamp, a light emitting diode (LED), a chemical laser, a solid state laser, an organic light emitting diode (OLED), an electroluminescent device, a fluorescent light, a gas discharge lamp, a metal halide lamp, a xenon arc lamp, and an induction lamp.
[0017] In another embodiment, the light source is tunable.
[0018] In another embodiment, the method further comprising filtering the interacted photons.
[0019] In another embodiment, the method further comprises filtering interacted photons, and the filtering interacted photons is performed by one or more of a fixed filter, a multi conjugate filter, and a conformal filter.
[0020] In another embodiment, the method further comprises determining the existence of the condition before generating photons, directing the generated photons, interacting the generated photons, directing the collected and interacted photons, and generating an image.
[0021] In another embodiment, determining the existence of the condition includes separate antecedent steps to the steps of generating photons, directing the generated photons, interacting the generated photons, and directing the collected and interacted photons, and the antecedent steps comprise: antecedently generating photons, antecedently collecting photons, antecedently interacting photons, and antecedently directing the photons, to thereby diagnose the condition.
DETAILED DESCRIPTION
[0022] This disclosure is not limited to the particular systems, devices and methods described, as these may vary. The terminology used in the description is for the purpose of describing the particular versions or embodiments only, and is not intended to limit the scope. [0023] As used in this document, the singular forms “a,” “an,” and “the” include plural references unless the context clearly dictates otherwise. Unless defined otherwise, all technical and scientific terms used herein have the same meanings as commonly understood by one of ordinary skill in the art. Nothing in this disclosure is to be construed as an admission that the embodiments described in this disclosure are not entitled to antedate such disclosure by virtue of prior invention. As used in this document, the term “comprising” means “including, but not limited to.”
[0024] The embodiments of the present teachings described below are not intended to be exhaustive or to limit the teachings to the precise forms disclosed in the following detailed description. Rather, the embodiments are chosen and described so that others skilled in the art may appreciate and understand the principles and practices of the present teachings.
Light Source
[0025] In an embodiment, at least one light source that generates photons that are directed to a human or animal. The light source is not limited and can be any source that is useful in providing the illumination. In an embodiment, the at least one light source may be used in concert with or attached to endoscope. Other ancillary requirements, such as power consumption, emitted spectra, packaging, thermal output, and so forth may be determined based on the particular application that the at least one light source is used. In some embodiments, the light source is a light element, which is an individual device that emits light. The light elements are not limited and may include an incandescent lamp, halogen lamp, light emitting diode (LED), chemical laser, solid state laser, organic light emitting diode (OLED), electroluminescent device, fluorescent light, gas discharge lamp, metal halide lamp, xenon arc lamp, induction lamp, or any combination of these light sources. In other embodiments, the light source is a light array, which is a grouping or assembly of more than one light element that are placed in proximity to each other.
[0026] In some embodiments, a light source has a particular wavelength that is intrinsic to the light element or to the light array. In other embodiments, the wavelength of the light sources is modified by filtering or tuning the photons that are emitted by the light source. In still other embodiments, light sources having different wavelengths are combined. The selected wavelength of a light source is not limited and can be one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), and near infrared-extended shortwave infrared (NIR- eSWIR) ranges. These correspond to wavelengths of about 180 nm to about 380 nm (UV), about 380 nm to about 720 nm (VIS), about 400 nm to about 1100 nm (VIS-NIR), about 850 nm to about 1800 nm (SWIR), about 1200 nm to about 2450 nm (eSWIR), and about 720 nm to about 2500 nm (NIR-eSWIR). The above ranges may be used alone or in combination of any of the listed ranges. Such combinations include adjacent (contiguous) ranges, overlapping ranges, and ranges that do not overlap.
[0027] Within the VIS light range, different colors of light can be employed alone or in combination. Violet light has a wavelength of about 380 to about 450 nm, blue light has a wavelength of about 450 to about 485 nm, cyan light has a wavelength of about 485 to about 500 nm, green light has a wavelength of about 500 nm to 565 nm, yellow light has a wavelength of about 565 nm to about 590 nm, orange light has a wavelength of about 590 nm to about 625 nm, and red light has a wavelength of about 625 nm to about 720 nm.
[0028] In some embodiments, the light source is a modulated light source. The choice of modulated light source and the techniques of modulating the light source are not limited. In some embodiments, the modulated light source is one or more of a filtered incandescent lamp, filtered halogen lamp, tunable LED array, tunable solid state laser array, tunable OLED array, tunable electroluminescent device, filtered fluorescent light, filtered gas discharge lamp, filtered metal halide lamp, filtered xenon arc lamp, filtered induction lamp, or any combination of these light sources. In some embodiments, tuning is accomplished by increasing or decreasing the intensity or duration at which the individual light elements are powered. Alternatively, tuning is accomplished by a fixed or tunable filter that filters light emitted by the individual light elements. In still other embodiments, the light source is not tunable. A light source that is not tunable cannot change its emitted light spectra, but it can be turned on and off by the appropriate controls.
[0029] In some embodiments, the light source comprises a quartz tungsten halogen light source. In other embodiments, the illumination source may comprise a metal halide light source, a light emitting diode (LED), a LED array having a uniform selection of emitters which emit over a constant wavelength range or a plurality of emitters which emit over a diversity of wavelength ranges, a pulsed LED, a pulsed LED array, a laser, a pulsed laser, a broadband illumination source, gas discharge light source, a fluorescent light source, an arc light source, a xenon arc lamp source, an LED light source in combination with phosphors and/or quantum dots, and the like and combinations thereof. The illumination sources are selected depending on the wavelengths of interest, and in particular whether a wavelength can not only be therapeutic, but also diagnostic in nature. Of the above, the lasers and/or LED light sources may be selected depending on the wavelengths of interest. The lasers may be gas discharge or solid state or semiconductor lasers and include helium-neon, argon, krypton, xenon ion, nitrogen, carbon monoxide, eximer, dye lasers such as stilbene, coumarin, and rhodamine, solid state or semiconductor lasers such as ruby, Nd:YAG, NdCrYAG, Nd:YLF, Nd:YV04, Nd:YCa404, Nd:YCa40(B03)3, Nd:glass, Tksapphire, Tr YAG, Tb:YAG, Yb doped glass, Ho:YAG, Cr:ZnSe, Ce:LiSAF, Ce:LiCAF, GaN, InGaN, AlGalnP, AlGaAs, InGaAsP, and lead salt, vertical cavity surface emitting lasers, quantum cascade laser, and hybrid silicon lasers. The illumination source may have a fixed spectral emission or may be tunable by combining sources, filtering, and/or modulating the sources and/or filters. Depending on the size, thermal output, power requirements, and so forth, the illumination source may be used directly within an a system, or remotely via optical fibers that are transparent to the desired wavelengths.
Therapy
[0030] The light sources of the present disclosure are configured so that, when activated, the light emitted by the light sources achieves therapeutic effects in a human or animal patient. The therapeutic effects are not limited. In one embodiment, the light achieves direct therapeutic effect by interacting with body tissue. In another embodiment, the light achieves direct therapeutic effect by interacting with the body tissue and the condition. In another embodiment, the light is used in photodynamic therapy where the application of light releases a therapeutic composition, and that therapeutic composition achieves the therapeutic effect. In yet another embodiment, the light simultaneously achieves direct therapeutic effect and photodynamic effect. In this embodiment, the direct therapeutic effect can be achieved by the light interacting with the body tissue, the condition, or both the body tissue and the condition. [0031] In some embodiments, the light has a direct therapeutic effect and is in the UV spectrum. In such configurations, the light can treat one or more of atopic dermatitis, psoriasis, vitiligo, acne vulgaris, cancer, and wounds. In other embodiments, the light has a direct therapeutic effect, and the wavelength of the light is one or more of UV, red, blue, NIR, VIS- NIR, SWIR, eSWIR, NIR-eSWIR, and full spectrum.
[0032] In still further embodiments, the light does not achieve a direct effect and is instead used to perform photodynamic therapy. During photodynamic therapy, the light is directed to a photosensitizer drug that releases therapeutically beneficial or therapeutically active compounds.
[0033] The list of conditions that respond to a treatment of the type disclosed herein is not limited and includes one or more of wounds, cancer, non-cancerous tumors, skin lesions, and precancerous skin lesions.
Visualization
[0034] For at least a portion of the time that light is emitted from the light source in order to achieve a therapeutic effect on a human or animal patient, the light is also used for visualization. The light that is used for simultaneous visualization and therapy is directed to the organs, skin, or other body tissues that are the subject of treatment. Examples of the light that is used for simultaneous visualization and therapy includes one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), and near infrared-extended shortwave infrared (NIR-eSWIR) ranges. In one embodiment, the light is ultraviolet (UV). In another embodiment, the spectral range of the light is alternated over time. Alternating or changing the spectral range of the light can be accomplished by switching light elements on or off individually, switching sections of the light array on or off individually, or switching an entire light array on or off.
[0035] Imaging is performed by filtering and detecting photons that are reflected from the body of the human or animal patient. The techniques and devices for filtering are not limited and include any of fixed filters, multi-conjugate filters, and conformal filters. In fixed filters, the functionality of the filter cannot be changed, though the filtering can be changed by mechanically moving the filter into or out of the light path. In some embodiments, the filter is a tunable filter that comprises a multi-conjugate filter. The multi-conjugate filter is an imaging filter with serial stages along an optical path in a Sole filter configuration. In such filters, angularly distributed retarder elements of equal birefringence are stacked in each stage with a polarizer between stages.
[0036] A conformal filter can filter a broadband spectra into one or more passbands. Example conformal filters include a liquid crystal tunable filter, an acousto-optical tunable filter, a Lyot liquid crystal tunable filter, an Evans Split-Element liquid crystal tunable filter, a Sole liquid crystal tunable filter, a Ferroelectric liquid crystal tunable filter, a Fabry Perot liquid crystal tunable filter, and combinations thereof.
[0037] In an embodiment, the image is collected by a camera chip. The camera chip is not limited, but in some embodiments is selected depending on the expected spectra that is reflected from the skin, tissues, or organs of the human or animal patient. In some embodiments, the camera chip is one or more of a charge coupled device (CCD), a complementary metal oxide semiconductor (CMOS), an indium gallium arsenide (InGaAs) camera chip, a platinum silicide (PtSi) camera chip, an indium antimonide (InSb) camera chip, a mercury cadmium telluride (HgCdTe) camera chip, or a colloidal quantum dot (CQD) camera chip. In some embodiments, each or the combination of the above-listed camera chips is a focal plane array (FPA). In some embodiments, each of the above camera chips includes quantum dots to tune their bandgaps thereby altering or expanding sensitivity to different wavelengths. The visualization techniques are not limited, and include one or more of VIS, NIR, SWIR, autofluorescence, or Raman spectroscopy.
[0038] Although visualization is mentioned, the disclosure is not so limited. For example, in some embodiments, the systems and methods include the ablation of body tissue by solid state lasers or chemical lasers. The tissue can be one or more of skin or organs.
[0039] In some embodiments, the visualization is performed at the same time or with at least some overlapping time with therapy. Such embodiments might be selected, for example, in situations where it is known or likely that a patient has a condition that needs to be treated. For example, a patient with a previously diagnosed condition can be safely visualized and treated at the same time without any prior diagnostic imaging. In such instances, the systems and methods described herein for performing visualization are confirmatory and can be used to analyze the condition as treatment continues.
[0040] In other embodiments, an additional antecedent series of visualization steps are performed before therapy. Such embodiments might be selected, for example, in situations where it is not known or not likely that a patient has a condition that needs to be treated. For example, for a patient suspected but not diagnosed with a condition, antecedent visualization will be performed before any treatment is performed. In such instance, the same systems and methods described herein are used to both diagnose and treat the condition. The antecedent visualization can, in certain embodiments, include the same steps described herein for visualization, but they are performed before any simultaneous treatment and visualization is performed.
[0041] In each of the above embodiments, the disclosure further contemplates that the same system or method performs both the visualization and the therapy, thereby saving time and resources. Furthermore, in those embodiments where the patient is known or likely to have a condition, the disclosure saves even further time and resources by enabling the same system or method to both treat and monitor the patient.
EXAMPLE
[0042] A tunable laser array light source was provided and includes two tunable laser light elements. When switched on, each laser light element produced a different wavelength. The light that was output from the light array was directed to a test tissue that contained a precancerous lesion. A photosensitizing agent was applied to the tissue. A dual polarization conformal filter was also placed to receive photons that interacted with the tissue. A CCD camera chip located on the opposite side of the conformal filter from the tissue was configured to output hyperspectral images of the tissue based on the photons that interacted with the tissue and were further modified by the dual polarization conformal filter.
[0043] During operation, the above configuration captured hyperspectral images and generated a ratiometric score image. The ratiometric score image had increased contrast in comparison to images that were not generated with the combination of the tuned light source and the dual polarization conformal filter. The increased contrast permitted easier identification of the precancerous lesion. At the same time during operation, the light that was produced by the tunable laser array light source also caused the photosensitizing agent to release therapeutically beneficial compounds. Thus, the precancerous legion was not only identified by imaging light that interacted with it, but therapeutic treatment was simultaneously performed by way of the release of the photosensitizing agent.
[0044] The present disclosure is not to be limited in terms of the particular embodiments described in this application, which are intended as illustrations of various features. Many modifications and variations can be made without departing from its spirit and scope, as will be apparent to those skilled in the art. Functionally equivalent methods and apparatuses within the scope of the disclosure, in addition to those enumerated herein, will be apparent to those skilled in the art from the foregoing descriptions. Such modifications and variations are intended to fall within the scope of the appended claims. The present disclosure is to be limited only by the terms of the appended claims, along with the full scope of equivalents to which such claims are entitled. It is to be understood that this disclosure is not limited to particular methods, reagents, compounds, compositions or biological systems, which can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting.
[0045] With respect to the use of substantially any plural and/or singular terms herein, those having skill in the art can translate from the plural to the singular and/or from the singular to the plural as is appropriate to the context and/or application. The various singular/plural permutations may be expressly set forth herein for sake of clarity.
[0046] It will be understood by those within the art that, in general, terms used herein, and especially in the appended claims (for example, bodies of the appended claims) are generally intended as “open” terms (for example, the term “including” should be interpreted as “including but not limited to,” the term “having” should be interpreted as “having at least,” the term “includes” should be interpreted as “includes but is not limited to,” et cetera). While various compositions, methods, and devices are described in terms of “comprising” various components or steps (interpreted as meaning “including, but not limited to”), the compositions, methods, and devices can also “consist essentially of’ or “consist of’ the various components and steps, and such terminology should be interpreted as defining essentially closed-member groups. It will be further understood by those within the art that if a specific number of an introduced claim recitation is intended, such an intent will be explicitly recited in the claim, and in the absence of such recitation no such intent is present.
[0047] For example, as an aid to understanding, the following appended claims may contain usage of the introductory phrases “at least one” and “one or more” to introduce claim recitations. However, the use of such phrases should not be construed to imply that the introduction of a claim recitation by the indefinite articles “a” or “an” limits any particular claim containing such introduced claim recitation to embodiments containing only one such recitation, even when the same claim includes the introductory phrases “one or more” or “at least one” and indefinite articles such as “a” or “an” (for example, “a” and/or “an” should be interpreted to mean “at least one” or “one or more”); the same holds true for the use of definite articles used to introduce claim recitations.
[0048] In addition, even if a specific number of an introduced claim recitation is explicitly recited, those skilled in the art will recognize that such recitation should be interpreted to mean at least the recited number (for example, the bare recitation of “two recitations,” without other modifiers, means at least two recitations, or two or more recitations). Furthermore, in those instances where a convention analogous to “at least one of A, B, and C, et cetera” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (for example, “a system having at least one of A, B, and C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, et cetera). In those instances where a convention analogous to “at least one of A, B, or C, et cetera” is used, in general such a construction is intended in the sense one having skill in the art would understand the convention (for example,
“a system having at least one of A, B, or C” would include but not be limited to systems that have A alone, B alone, C alone, A and B together, A and C together, B and C together, and/or A, B, and C together, et cetera). It will be further understood by those within the art that virtually any disjunctive word and/or phrase presenting two or more alternative terms, whether in the description, claims, or drawings, should be understood to contemplate the possibilities of including one of the terms, either of the terms, or both terms. For example, the phrase “A or B” will be understood to include the possibilities of “A” or “B” or “A and B.”
[0049] In addition, where features of the disclosure are described in terms of Markush groups, those skilled in the art will recognize that the disclosure is also thereby described in terms of any individual member or subgroup of members of the Markush group.
[0050] As will be understood by one skilled in the art, for any and all purposes, such as in terms of providing a written description, all ranges disclosed herein also encompass any and all possible subranges and combinations of subranges thereof. Any listed range can be easily recognized as sufficiently describing and enabling the same range being broken down into at least equal halves, thirds, quarters, fifths, tenths, et cetera. As a non-limiting example, each range discussed herein can be readily broken down into a lower third, middle third and upper third, et cetera. As will also be understood by one skilled in the art all language such as “up to,” “at least,” and the like include the number recited and refer to ranges that can be subsequently broken down into subranges as discussed above. Finally, as will be understood by one skilled in the art, a range includes each individual member. Thus, for example, a group having 1-3 cells refers to groups having 1, 2, or 3 cells. Similarly, a group having 1-5 cells refers to groups having 1, 2, 3, 4, or 5 cells, and so forth.
[0051] Various of the above-disclosed and other features and functions, or alternatives thereof, may be combined into many other different systems or applications. Various presently unforeseen or unanticipated alternatives, modifications, variations or improvements therein may be subsequently made by those skilled in the art, each of which is also intended to be encompassed by the disclosed embodiments.

Claims

1. A method of imaging and treating a condition of a tissue, the method comprising: generating photons with a light source; directing the generated photons to a tissue, said tissue comprising the condition; interacting the generated photons with the tissue, the condition, or both the tissue and the condition in order to treat the condition, simultaneously to the interacting, collecting interacted photons that have interacted with the tissue, the condition, or both the tissue and the condition; directing the collected and interacted photons to a camera chip, generating, by way of the camera chip, an image from the collected, interacted photons.
2. The method of claim 1 , wherein the condition is one or more of a wound, a cancer, a non- cancerous tumor, a skin lesion, or a pre-cancerous skin lesion.
3. The method of claim 1, wherein treating the condition is performed photodynamically.
4. The method of claim 3, wherein the photodynamic treatment includes application of a photosensitizing agent to one or more of the tissue or the condition.
5. The method of claim 1, wherein treating the condition is performed by the direct therapeutic effect of interacting the generated photons with the tissue or the condition.
6. The method of claim 1 , wherein treating the condition is performed photodynamically by applying a photosensitizing agent to one or more of the tissue or the condition and by the direct therapeutic effect of interacting the generated photons the tissue or the condition.
7. The method of claim 1, wherein the generated photons have wavelengths of one or more of ultraviolet (UV), visible (VIS), near infrared (NIR), visible-near infrared (VIS-NIR), shortwave infrared (SWIR), extended shortwave infrared (eSWIR), or near infrared-extended shortwave infrared (NIR-eSWIR).
8. The method of claim 7, wherein the generated photons are VIS and have one or more wavelength ranges corresponding to violet, blue, cyan, green, yellow, orange, or red.
9. The method of claim 7, wherein the generated photons are UV.
10. The method of claim 1, wherein the light source comprises one or more of an incandescent lamp, a halogen lamp, a light emitting diode (LED), a chemical laser, a solid state laser, an organic light emitting diode (OLED), an electroluminescent device, a fluorescent light, a gas discharge lamp, a metal halide lamp, a xenon arc lamp, and an induction lamp.
11. The method of claim 1 , wherein the light source is tunable.
12. The method of claim 1, further comprising filtering the interacted photons.
13. The method of claim 12, wherein the filtering is performed by one or more of a fixed filter, a multi-conjugate filter, and a conformal filter.
14. The method of claim 1, further comprising determining the existence of the condition before generating photons, directing the generated photons, interacting the generated photons, directing the collected and interacted photons, and generating an image.
15. The method of claim 14, wherein the determining the existence of the condition includes separate antecedent steps to the steps of generating photons, directing the generated photons, interacting the generated photons, and directing the collected and interacted photons, and the antecedent steps comprise: antecedently generating photons, antecedently collecting photons, antecedently interacting photons, and antecedently directing the photons, to thereby diagnose the condition.
PCT/US2021/032527 2020-05-14 2021-05-14 Systems and methods for simultaneous wound detection and therapy Ceased WO2021231913A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN202180048387.6A CN115867199A (en) 2020-05-14 2021-05-14 Systems and methods for simultaneous wound detection and treatment
JP2022568673A JP2023526026A (en) 2020-05-14 2021-05-14 Systems and methods for simultaneous wound detection and treatment
EP21804665.4A EP4149359A4 (en) 2020-05-14 2021-05-14 SYSTEMS AND METHODS FOR SIMULTANEOUS MIRACLE DETECTION AND THERAPY

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063024728P 2020-05-14 2020-05-14
US63/024,728 2020-05-14

Publications (1)

Publication Number Publication Date
WO2021231913A1 true WO2021231913A1 (en) 2021-11-18

Family

ID=78512356

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/032527 Ceased WO2021231913A1 (en) 2020-05-14 2021-05-14 Systems and methods for simultaneous wound detection and therapy

Country Status (5)

Country Link
US (1) US20210353148A1 (en)
EP (1) EP4149359A4 (en)
JP (1) JP2023526026A (en)
CN (1) CN115867199A (en)
WO (1) WO2021231913A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220367754A1 (en) * 2021-05-14 2022-11-17 Innovation Semiconductor Monolithic color-tunable light emitting diodes and methods thereof
FI131516B1 (en) * 2022-06-22 2025-06-03 Danvantar Biophotonics Oy Skin characterization device
FI20236255A1 (en) 2023-11-10 2025-05-11 Danvantar Biophotonics Oy Apparatuses, system and method for characterization and treatment of skin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
US20030036785A1 (en) * 1992-12-28 2003-02-20 Yoshiteru Ii Medical laser apparatus and diagnostic/treatment apparatus using the medical laser apparatus
US20030153825A1 (en) * 2002-02-12 2003-08-14 Science & Engineering Associates, Inc. Cancer detection and adaptive dose optimization treatment system
US20080214940A1 (en) * 2007-03-02 2008-09-04 Benaron David A Medical imaging lens system, and method with high-efficiency light collection and collinear illumination
US20120209125A1 (en) * 2011-02-10 2012-08-16 Physical Sciences, Inc. Singlet Oxygen Production and Dosimetry for Photodynamic Therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527350A (en) * 1993-02-24 1996-06-18 Star Medical Technologies, Inc. Pulsed infrared laser treatment of psoriasis
US20080051773A1 (en) * 1997-10-08 2008-02-28 Sergei Ivanov Automated Treatment of Psoriasis
AT505280B1 (en) * 2007-06-11 2008-12-15 Univ Wien Tech DEVICE FOR IRRADIATING TISSUE WITH LIGHT
DE112016006140T5 (en) * 2016-02-29 2018-09-13 Olympus Corporation Imaging / projection device with optical scanning and endoscope system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973848A (en) * 1989-07-28 1990-11-27 J. Mccaughan Laser apparatus for concurrent analysis and treatment
US20030036785A1 (en) * 1992-12-28 2003-02-20 Yoshiteru Ii Medical laser apparatus and diagnostic/treatment apparatus using the medical laser apparatus
US20030153825A1 (en) * 2002-02-12 2003-08-14 Science & Engineering Associates, Inc. Cancer detection and adaptive dose optimization treatment system
US20080214940A1 (en) * 2007-03-02 2008-09-04 Benaron David A Medical imaging lens system, and method with high-efficiency light collection and collinear illumination
US20120209125A1 (en) * 2011-02-10 2012-08-16 Physical Sciences, Inc. Singlet Oxygen Production and Dosimetry for Photodynamic Therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP4149359A4 *

Also Published As

Publication number Publication date
EP4149359A4 (en) 2024-06-05
JP2023526026A (en) 2023-06-20
US20210353148A1 (en) 2021-11-18
EP4149359A1 (en) 2023-03-22
CN115867199A (en) 2023-03-28

Similar Documents

Publication Publication Date Title
EP4149359A1 (en) Systems and methods for simultaneous wound detection and therapy
US9550072B2 (en) Diagnostic device, therapeutic device, and uses thereof
US20040081621A1 (en) Optical imaging method, and an apparatus for optical imaging
Monnier et al. Photodetection and photodynamic therapy of ‘early’squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree
US8313426B2 (en) Endoscope system
US4973848A (en) Laser apparatus for concurrent analysis and treatment
US12268355B2 (en) Discrimination of calculi and tissues with molecular chemical imaging
US11234584B2 (en) Molecular chemical imaging endoscopic imaging systems
JPH10113327A (en) Endoscope device
JP2004530464A (en) Apparatus and method for photocosmetic and photoderma procedures
WO2014119546A1 (en) Light source device, subject observation device and light source control method
CN114451850A (en) Imaging device and method, and capsule endoscope
WO2017137350A1 (en) Wavelength tuneable led light source
Scott et al. Fluorescence photodiagnostics and photobleaching studies of cancerous lesions using ratio imaging and spectroscopic techniques
CN115103625A (en) System and method for tissue target discrimination
JPH01151436A (en) Apparatus for diagnosis and treatment of cancer
RU2736909C1 (en) Method for photodynamic diagnostics and therapy of central lung cancer and device for implementation thereof
Cubeddu et al. Tumour visualization in a murine model by time-delayed fluorescence of sulphonated aluminium phthalocyanine
JP7546204B2 (en) Light emitting device and endoscope system
Gryko et al. Semiconductor lasers vs LEDs in diagnostic and therapeutic medicine
JP2738390B2 (en) Diagnosis and treatment equipment
Cubeddu et al. Multispectral and lifetime imaging for the detection of skin tumors
Koenig et al. In vivo fluorescence spectroscopy and imaging of ALA-induced endogenous porphyrins in skin after Er: YAG ablation of human stratum corneum
Petri et al. Prevention of severe photosensitivity after m-THPC IPDT with a natural antioxidant agent
McKechnie et al. Optimization of 5-aminolaevulinic acid application and light excitation to ensure maximum contrast between cancerous and healthy tissue on the skin

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21804665

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2022568673

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2021804665

Country of ref document: EP

Effective date: 20221214

WWW Wipo information: withdrawn in national office

Ref document number: 2021804665

Country of ref document: EP